Bellecapital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bellecapital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,199	Closed	-$477K	–	192
2021 Q1	$477K	Hold	2,199	–	–	0.15%	112
2020 Q4	$254K	Buy	+2,199	New	+$246K	0.08%	162
2020 Q3	–	Sell	-1,697	Closed	-$208K	–	173
2020 Q2	$208K	Buy	+1,697	New	+$193K	0.1%	150

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Bellecapital's GWPH Position: Q2 2021 in Review

Bellecapital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,199 shares — an estimated $477K sold.

Bellecapital first reported a position in GWPH in Q2 2020 and held it in 3 quarters. The position peaked at $477K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Bellecapital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Bellecapital sold 2,199 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $477K.
Bellecapital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2020 and held it in 3 quarters.
Bellecapital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $477K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Bellecapital's 13F filing for Q2 2021, filed 28 Jul 2021.